Technical Analysis for CRSP - CRISPR Therapeutics AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical CRSP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Multiple of Ten Bullish | Other | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Doji - Bearish? | Reversal | 1.15% | |
| Multiple of Ten Bearish | Other | 1.15% | |
| Overbought Stochastic | Strength | 1.15% | |
| 200 DMA Support | Bullish | 0.82% | |
| Multiple of Ten Bearish | Other | 0.82% | |
| BB Squeeze Ended | Range Expansion | 0.82% | |
| Overbought Stochastic | Strength | 0.82% | |
| Up 3 Days in a Row | Strength | 0.82% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 1.5x Volume Pace | about 19 hours ago |
| Up 2% | about 19 hours ago |
| Upper Bollinger Band Resistance | about 19 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Up 1% | about 19 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/26/2021
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 220.15 |
| 52 Week Low | 68.85 |
| Average Volume | 1,286,463 |
| 200-Day Moving Average | 125.64 |
| 50-Day Moving Average | 119.29 |
| 20-Day Moving Average | 121.92 |
| 10-Day Moving Average | 127.16 |
| Average True Range | 5.49 |
| ADX | 15.4 |
| +DI | 27.47 |
| -DI | 16.63 |
| Chandelier Exit (Long, 3 ATRs) | 116.42 |
| Chandelier Exit (Short, 3 ATRs) | 126.16 |
| Upper Bollinger Bands | 133.78 |
| Lower Bollinger Band | 110.06 |
| Percent B (%b) | 0.87 |
| BandWidth | 19.45 |
| MACD Line | 3.57 |
| MACD Signal Line | 2.52 |
| MACD Histogram | 1.0448 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 137.09 | ||||
| Resistance 3 (R3) | 137.11 | 135.01 | 136.02 | ||
| Resistance 2 (R2) | 135.01 | 133.38 | 134.99 | 135.66 | |
| Resistance 1 (R1) | 132.84 | 132.37 | 133.93 | 132.82 | 135.31 |
| Pivot Point | 130.74 | 130.74 | 131.28 | 130.72 | 130.74 |
| Support 1 (S1) | 128.57 | 129.11 | 129.66 | 128.55 | 126.05 |
| Support 2 (S2) | 126.47 | 128.10 | 126.45 | 125.70 | |
| Support 3 (S3) | 124.30 | 126.47 | 125.34 | ||
| Support 4 (S4) | 124.28 |
